Research and analysis

Diabetes outcomes versus expenditure (DOVE) in local populations

The DOVE tool shows the relationship between spending on diabetes care and clinical outcomes in GP and clinical commissioning group (CCG) areas.

Documents

DOVE tool for CCGs and GP practices

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

DOVE tool: summary of results 2013 to 2018

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Healthcare professionals can use the DOVE tool to explore the relationship between spending on diabetes treatment and local clinical outcomes for patients. This can help with planning and commissioning local services.

The tool includes clinical outcomes from the National Diabetes Audit (NDA) and Quality Outcomes Framework (QOF), and prescribing data from the Health and Social Care Information Centre (now NHS Digital).

Guidance for users is included in the tool.

‘Briefing for the Diabetes Outcomes Versus Expenditure (DOVE) tool: overview to 2018’ gives an overview of the tool and presents data from 2013 to 2014, to 2017 to 2018, showing how spend on diabetes medications and the proportion of patients achieving recommended blood glucose levels varies between general practices (GPs) and clinical commissioning groups (CCGs), and how it has changed over time.

Updates to this page

Published 12 February 2016
Last updated 5 March 2019 + show all updates
  1. Added: 'Briefing for the Diabetes Outcomes Versus Expenditure (DOVE) tool: summary of results 2013 to 2018'.

  2. First published.

Sign up for emails or print this page